Glycine Encephalopathy

Sponsored diagnostic testing programs for Glycine Encephalopathy

Glycine encephalopathy (nonketotic hyperglycinemia) is a metabolic disorder characterized by elevated glycine in body fluids, leading to neonatal hypotonia, seizures, apnea, and later developmental delay or intellectual disability. Severity ranges from lethal neonatal forms to attenuated presentations. Genetic testing confirms the diagnosis and informs management and counseling.

1 program found for Glycine Encephalopathy

Programs

1 program
Invitae Unlock™

Invitae Epilepsy Panel

This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.

Neurology